Background. Numerous gaseous microemboli (GME) are delivered into the arterial circulation during cardiopulmonary bypass (CPB). These emboli damage end organs through multiple mechanisms that are thought to contribute to neurocognitive deficits after cardiac surgery. Here, we use hypobaric oxygenation to reduce dissolved gases in blood and greatly reduce GME delivery during CPB.
Methods. Variable subatmospheric pressures were applied to 100% oxygen sweep gas in standard hollow fiber microporous membrane oxygenators to oxygenate and denitrogenate blood. GME were quantified using ultrasound while air embolism from the surgical field was simulated experimentally. We assessed end-organ tissues in swine postoperatively using light microscopy.
Results. Variable sweep gas pressures allowed reliable oxygenation independent of carbon dioxide removal while denitrogenating arterial blood. Hypobaric oxygenation produced dose-dependent reductions of Doppler signals produced by bolus and continuous GME loads in vitro. Swine were maintained using hypobaric oxygenation for 4 hours on CPB with no apparent adverse events. Compared with current practice standards of oxygen/air sweep gas, hypobaric oxygenation reduced GME volumes exiting the oxygenator (by 80%), exiting the arterial filter (95%), and arriving at the aortic cannula (w100%), indicating progressive reabsorption of emboli throughout the CPB circuit in vivo. Analysis of brain tissue suggested decreased microvascular injury under hypobaric conditions.
Conclusions. Hypobaric oxygenation is an effective, low-cost, common sense approach that capitalizes on the simple physical makeup of GME to achieve their neartotal elimination during CPB. This technique holds great potential for limiting end-organ damage and improving outcomes in a variety of patients undergoing extracorporeal circulation.
(Ann Thorac Surg 2014;97:879-87) Ó 2014 by The Society of Thoracic Surgeons C ardiac surgery is frequently complicated by postoperative neurocognitive deficits that degrade functional capacity and quality of life while increasing health care costs [1] . Multifactorial contributors to this significant public health problem likely include gaseous microemboli [2] . The arterial circulation receives thousands of 10 to 40 mm gaseous microemboli (GME) during cardiopulmonary bypass (CPB) despite the use of membrane oxygenation and arterial filtration [3, 4] . Vasoocclusive GME cause tissue ischemia and denude endothelium in the brain and other end organs, leading to vascular dilation, increased permeability, activation of platelets and clotting cascades, and recruitment of complement and cellular mediators of inflammation [5, 6] . As current technologies only partially remove GME from CPB circuits, we sought to develop a novel approach to eliminate GME using well-described principles of gas exchange [7] .
Current perfusion practice generally targets mildly hyperoxic blood gases during CPB. This target is achieved by lowering the partial pressure of oxygen in oxygenator sweep gas by dilution with air, thereby engendering the needless side effect of dissolving nitrogen in blood. The blood, thus saturated with dissolved gas, is poorly able to dissolve gases that exist in bubble form as GME. Here, we
The Appendix can be viewed in the online version of this article [http://dx.doi.org/10.1016/j.athoracsur.2013. 08.074] on http://www.annalsthoracicsurgery.org. employed the novel strategy of hypobaric oxygenation to lower the pressure of pure oxygen sweep gas without dilution, thus achieving mildly hyperoxic blood gases in the absence of nitrogen. This approach lowered the sum of partial pressures of dissolved gases to subatmospheric levels, thereby creating a powerful gradient for reabsorption of GME into the aqueous phase. We used in vitro and in vivo approaches to characterize the elimination of GME from CPB circuits using hypobaric oxygenation, which was accompanied by a reduction in dilated brain capillaries in swine.
Material and Methods

Hypobaric Oxygenation Apparatus
Our approach to achieving hypobaric oxygenation is described in Figure 1A and 
In Vitro Gas Exchange
Our approach to in vitro gas exchange experiments is described in Figure 1B and its legend. Materials listed are the following: Sarns 9000 heart-lung machine with Delphin centrifugal pumps (Terumo Cardiovascular, Ann Arbor, MI); RX25R hardshell reservoirs (200 mL minimum operating volume; Terumo), Capiox RX-25 oxygenators (1,000 mm Hg allowable trans-fiber operating gradient; Terumo); Normosol (Hospira Incorporated, Lake Forest, IL); human red blood cells (RBCs) and fresh frozen plasma (FFP) (Hartford Hospital Blood Bank, exempt from Institutional Review Board review); CPB heater (ECMO-Temp, Zimmer Incorporated, Dover, OH); and I-Stat blood gas analyzer (G3þ cartridges; Abbott Laboratories, Green Oaks, IL). To assess the effect of sweep gas pressure on blood pressure at the oxygenator outlet, paired measurements were performed at sweep gas pressures of ambient, 0.5 atmospheres absolute (ata), and 0.1 ata (n ¼ 14 trials per condition). Blood pressure was measured using a pressure transducer (ICU Medical, San Clemente, CA) connected to a demodulator (Validyne Engineering Corporation, Northridge, CA), whose voltage output was calibrated against a water column, digitized (DI-145), and recorded using Windaq software (DATAQ Instruments, Akron, OH).
In Vitro GME Our approach to measuring GME removal in vitro is described in Figure 2A 
Swine CPB
Eight juvenile swine were studied in compliance with the 1996 Guide for the Care and Use of Laboratory Animals and with approval of Hartford Hospital's Institutional Animal Care and Use Committee. Anesthetic induction employed intramuscular acepromazine (1.1 mg/kg), glycopyrrolate (0.01 mg/kg), and ketamine (33 mg/kg), followed by 3% isoflurane inhalation with electrocardiography and pulse oximetry. Fentanyl (50 mcg in 5 mL normal saline) was administered into the lumbar cerebrospinal fluid through a 20-gauge multi-orifice catheter. Tracheal intubation and ear vein cannulation were followed by isoflurane maintenance in 70% oxygen (O 2 )/30% nitrogen and 50 mcg of additional spinal fentanyl when warranted by hemodynamics. After median sternotomy, a central arterial pressure catheter was placed and heparin was administered intravenously to achieve and maintain activated clotting time greater than 350 seconds (Hemochron Response, International Technidyne Corporation, Edison, NJ). Aortic (20-french) and bicaval (28 to 30-french) CPB cannulae (Medtronic Incorporated, Minneapolis, MN) were inserted.
Animals were assigned a priori to control or hypobaric oxygenation conditions, which were achieved using a single-oxygenator, filtered CPB circuit ( Fig 3A) . An M3 Detector (Spectrum Medical, Cheltenham, UK) continuously monitored flow rates and arterial and venous O 2 saturations (SaO 2 /SvO 2 ). Partial pressure of oxygen in arterial blood (PaO 2 ) was adjusted (target ¼ 200 mm Hg) by varying the sweep gas oxygen/air mixture (control conditions, N ¼ 3 animals) or by applying variable subatmospheric pressure to 100% O 2 sweep gas (hypobaric oxygenation, N ¼ 5 animals). Partial pressure of carbon dioxide in arterial blood (PaCO 2 ) (target ¼ 45 mm Hg) was adjusted by varying the sweep gas flow rate in each condition. In the hypobaric condition, the predicted partial pressure of isoflurane was maintained by increasing the vaporizer dial setting to equal the desired concentration/ sweep gas pressure (eg, if 1% isoflurane were used at ambient pressure, the setting would need to be increased to 1.5% at 0.66 atmospheres absolute (ata) and to 2% at 0.5 ata to achieve an equal hypnotic effect) [8, 9] . The CPB flow rate was adjusted to maintain venous oxygen saturation (SvO 2 ) greater than 60%, and intermittent phenylephrine maintained mean arterial pressure (MAP) greater than 50 mm Hg. Reservoir volume was 250 to 500 mL. To conserve the animals' low starting hematocrit, mediastinal shed blood was returned to the reservoir's cardiotomy section by a 1/4" roller pump circuit. Vacuum-assisted venous drainage was used (-10 mm Hg). Passive cooling was allowed to 34 C. Air was continuously entrained throughout the CPB run (200 mL/minute, through a Luer connector in venous line at reservoir entrance; Fig 3A) . Single-site Doppler monitored GME semi-quantitatively in all 8 experiments. Terumo's Food and Drug Administration-approved Emboli Detection and Classification (EDAC) was available in 6 of 8 experiments for simultaneous 3-site ultrasound backscatter GME quantification [10] : at preoxygenator, immediately post filter, and either post oxygenator (N ¼ 3 animals) or 6 feet post filter (N ¼ 3) locations. The GME data were acquired in trials of 10 to 120 minutes duration separated by a change in CPB conditions (eg, flow rate, reservoir volume, sweep gas composition or pressure). Brief trials of hypobaric oxygenation were performed in 2 of 3 animals otherwise managed with control conditions. Thus, hypobaric data are from N ¼ 7/8 animals for Doppler and N ¼ 5/6 animals for EDAC, while all control data are from N ¼ 3 animals (number of trials [n] listed in Results). As CPB parameters are likely larger determinants of microembolization than the animal downstream of the CPB circuit, GME data trials were considered to be independent observations for statistical analysis [11] .
Hematologic samples taken before CPB, then after 2 and 4 hours of CPB, were analyzed for RBC morphology and plasma hemoglobin. End organs were fixed with neutral buffered formalin (10%, 3 L, 5 minutes) administered through the CPB circuit before harvest.
Swine Tissue Analysis
Paraffin-embedded, 4-mm hematoxylin-eosin sections from the frontal lobe, thalamus, caudal lobe, mesencephalon, cerebellum, medulla, and renal cortex were evaluated microscopically by veterinary pathologists for cytoarchitectural integrity. Then, blinded quantification of dilated capillaries (>10 mm diameter) was performed in white matter adjacent to the lateral ventricle and subependymal zone (periventricular white matter, w10 10Â fields per animal). Due to the expected heterogeneous nature of tissue effects and the exploratory nature of the post hoc microvascular analysis, we treated each field as an independent data point with respect to microvascular injury. Hypobaric oxygenation apparatus. Pure oxygen is supplied to the sweep gas inlet of a standard hollow fiber microporous membrane oxygenator with a sealed housing. A regulated vacuum source at the sweep gas outlet applies user-determined variable subatmospheric pressure to the sweep gas compartment to regulate the partial pressure gradient for blood oxygenation. A vacuum gauge measures the pressure applied, while a positive-pressure relief valve (PPR) ensures against creation of positive pressures. A needle-valve flowmeter at the sweep gas inlet regulates sweep gas flow rate and thus carbon dioxide (CO 2 ) removal, while allowing a pressure drop from ambient to subatmospheric. (B) In vitro gas exchange circuit. A mixture of human red blood cells, FFP, and minimal crystalloid (hematocrit w 30%) from a cardiopulmonary bypass (CPB) reservoir is pumped (3.5 L/minute) to the CPB oxygenator (37 C), where oxygenation occurs with pure oxygen sweep gas at variable subatmospheric pressure. The blood then passes into a patient simulator consisting of a reservoir, pump, and oxygenator that removes O 2 and adds CO 2 using pure CO 2 sweep gas at very low pressure (1 L/minute, 0.1 atmospheres absolute). Blood gases were sampled downstream of the CPB oxygenator (arterial) and the patient simulator (venous, n ¼ 3 samples per condition). The simulated patient produced normal venous blood gas values. (C) and (D) Application of subatmospheric sweep gas pressure in the CPB oxygenator reduced arterial oxygenation in the expected linear manner independent of CO 2 removal.
Statistics
Data are presented as mean AE standard error of the mean. Continuous variables were compared using 2-tailed Student t tests (significance at p < 0.05). A linear fit was performed using Prism (GraphPad Software, La Jolla, CA). Dose-dependence was assessed using the Spearman rank correlation coefficient. The GME data trials and tissue specimens were treated as independent observations for statistical analyses.
Results
In Vitro Gas Exchange: Reduction of Dissolved Gases in Blood
We used hypobaric oxygenation ( Fig 1A) and a simulated patient on CPB (Fig 1B) to assess the effect of subatmospheric sweep gas pressures on oxygenation and CO 2 removal from blood in the absence of nitrogen. As expected, lowering the pressure of pure oxygen sweep gas decreased PaO 2 in a smooth, linear manner (Table 1 ; Fig 1C; R 2 ¼ 0.99). In contrast, PaCO 2 was largely stable with decreasing sweep gas pressures, with possibly increased efficiency of CO 2 removal at the lowest pressures applied (Table 1 ; Fig 1D) . Indeed, CO 2 removal was easily managed independently of oxygenation by adjusting the sweep gas flow rate in our experiments. Hypobaric oxygenation was confirmed to reduce dissolved nitrogen in blood by 85.4% AE 0.7% using mass spectroscopy (n ¼ 3 trials, p < 0.001, denitrogenation likely underestimated (see Appendix). No detrimental effects on the oxygenator or gas exchange were observed in any experiments. During simulated vacuum failure, the positive-pressure relief valve successfully prevented air embolism (data not shown). Together, these data indicate that hypobaric oxygenation is a reliable, efficient method for managing gas exchange during CPB that reduces the sum of partial pressures of dissolved gases to subatmospheric levels. In Vitro GME: Dose-Dependent Removal
We next tested whether hypobaric oxygenation improves GME removal in the CPB circuit. First, GME boluses were injected upstream of the oxygenator (Fig 2A) . When the oxygenator used 100% oxygen sweep gas at ambient pressure, a robust downstream Doppler signal was observed (Fig 2B) . Modest reduction of sweep gas pressure to 0.9 ata reduced the Doppler signal by 94.8% AE 1.0% from control (area under curve, range 90.9% to 98.3%, n ¼ 9 trials, p < 0.001), while at 0.8 ata the signal was barely discernible (reduced 99.6% AE 0.07% from control, range 99.3% to 99.8%, n ¼ 10 trials, p < 0.001). Next, air entrainment simulated a large ongoing embolic load. Reductions in sweep gas pressure again produced a robust dose-dependent reduction of the Doppler signal measured before the arterial filter (Fig 2C, reduced by 26% AE 3% when the sweep gas pressure was 0.9 ata, 66% AE 2% at 0.8 ata, 83% AE 2% at 0.7 ata, 91% AE 0.2% at 0.6 Histograms showing EDAC GME counts and sizes at the 4 monitoring sites for both control (O 2 /air sweep gas at ambient pressure) and hypobaric (O 2 sweep gas at subatmospheric pressure) conditions. Under control conditions approximately 4,500 GME/minute were delivered to the patient. Under hypobaric conditions, GME counts and volumes were similar to control at the pre-oxygenator location, but were progressively eliminated as they traversed the CPB circuit, reducing GME delivery to only 2/minute during this large embolic load.
ata, 95% AE 2% at 0.5 ata, and 98% AE 1% at 0.4 ata, Spearman's rank correlation coefficient r ¼ 1.0, n ¼ 3 continuous trials). When the Doppler was moved downstream of the arterial filter, a substantial embolic signal persisted under normobaric conditions despite the use of arterial filtration (81% AE 3% of pre-filter baseline signal; Fig 2D) . The downstream signal was reduced even more effectively by reductions in sweep gas pressure (by 53% AE 4% of post-filter baseline at 0.9 ata, 83% AE 2% at 0.8 ata, 94% AE 1% at 0.7 ata, 99% AE 0.3% at 0.6 ata, 99.5% AE 0.1% at 0.5 ata, and 99.7% AE 0.1% at 0.4 ata, r ¼ 1.0, n ¼ 3 continuous trials). Together these data demonstrate that the use of hypobaric oxygenation improves the ability of the CPB circuit to remove GME from circulating blood in a dose-dependent fashion. The data also suggest that hypobaric oxygenation is most effective when used along with, rather than instead of, arterial filtration to reduce embolic burden.
Swine CPB: Safe Maintenance of Large Animals
The CPB in 40 kg swine using hypobaric oxygenation was characterized by stable, easily adjustable gas exchange parameters with no adverse effects noted in the animal, oxygenator, or CPB circuit. Animal characteristics and CPB management data are listed in Table 2 . Notably, lowering the partial pressure of oxygen in the sweep gas using dilution with nitrogen (FIO 2 ¼ 68.3% AE 1.7% in control) or using vacuum (pressure ¼ 0.66 AE 0.03 ata in hypobaric conditions) produced similar PaO 2 values, suggesting that hypobaric oxygenation preserves oxygenator gas exchange efficiency. A small increase in CO 2 tension in control animals was due to a slightly lower sweep gas flow rate in the absence of vacuum. Overall, hypobaric oxygenation was a reliable, practical method for maintaining large animals during CPB.
Swine GME: Progressive Elimination in the CPB Circuit During continuous air entrainment, single-site semiquantitative Doppler and multisite quantitative EDAC detected GME in the CPB circuit (Fig 3A) . Data were collected in discrete trials (n) separated by a change in CPB parameters in N ¼ 8 total swine. Hypobaric oxygenation reduced the Doppler signal near the aortic cannula by 99.1% AE 0.3% (range 95.8% to 100%, n ¼ 16 trials, N ¼ 7 swine) compared with control (n ¼ 7, N ¼ 3). The EDAC data from hypobaric (N ¼ 5 swine) and control (N ¼ 3) conditions are presented in Figure 3B . Proximal to the oxygenator, EDAC GME counts and volumes were similar between hypobaric (n ¼ 10 trials, p > 0.29) and control (n ¼ 7). Downstream from the oxygenator, GME numbers in the hypobaric condition were greatly reduced compared with controls: at the post-oxygenator location by 68.4% AE 14.1% (range 13.1% to 91.3%, n ¼ 5, p < 0.05), at the post-arterial filter location by 92.6% AE 4.2% (range 57.8% to 99.8%, n ¼ 10, p < 0.01), and at the entering patient location by 99.96% AE 0.02% (range 99.87% to 99.99%, n ¼ 5, p < 0.001). The GME volumes were also reduced at the post-oxygenator location by 80.5% AE 5.6% (range 62.2% to 95.6%, n ¼ 5, p < 0.05), at the post-filter location by 94.9% AE 2.9% (range 74.3% to 99.8%, n ¼ 10, p < 0.01), and at the entering patient location by 99.97% AE 0.01% (range 99.94% to 100%, n ¼ 5, p < 0.001). Control trials numbered n ¼ 3, 7, and 4 in these respective locations. These data demonstrate that hypobaric oxygenation strongly enhances GME removal from the CPB circuit in vivo. Further, they indicate that the site of enhanced GME removal extends progressively from the oxygenator to the arterial filter to the blood itself as it flows toward the patient. Importantly, data acquired closest to the patient show near total elimination of GME delivery from the CPB circuit by the combined use of arterial filtration As the cylindrical hollow fiber microporous oxygenator membranes are not expected to transfer pressures from the sweep gas compartment into the blood phase, we do not expect blood cells to experience hypobaric pressures. Indeed, subatmospheric sweep gas pressures did not affect arterial line blood pressures at the oxygenator outlet (differences from control ranged from -0.8 to þ0.6 mm Hg at 0.5 ata (n ¼ 14 trials, p > 0.9) and from -0.6 to þ0.5 mm Hg at 0.1 ata (n ¼ 14 trials, p > 0.4). Additionally, no plasma hemoglobin or morphologic evidence of hemolysis was observed in blood samples taken before and during hypobaric oxygenation in swine (Appendix Fig 1A) .
Experienced veterinary pathologists generally found no cytoarchitectural abnormality or apparent difference between animals in fixed postmortem tissue from six brain regions and the renal cortex (Appendix Fig 1B-D) . However, the presence of abnormal dilated capillaries in some white matter regions was noted. Because small capillary and arteriolar dilations are known responses to microembolization [5] , we asked whether this finding was related to the CPB strategy employed. Blinded post-hoc analysis in periventricular white matter revealed that reduction of GME during hypobaric oxygenation was accompanied by 35.8% AE 5.5% and 48.7% AE 5.7% reductions in the number and area of dilated capillaries, respectively (Fig 4B and C , p < 0.001) when compared with control. Similar findings were observed at all capillary diameters studied (Fig 4D) . Collectively, these data suggest that elimination of GME is accompanied by reduced microvascular injury in animals maintained using hypobaric oxygenation.
Comment
Mechanism
Hypobaric oxygenation controls the oxygenator's gas to blood O 2 diffusion gradient to achieve desired blood gases without using nitrogen. The resultant decrease in dissolved blood gases (see Appendix) favors aqueous reabsorption of GME, likely explaining the enhanced GME removal observed throughout the CPB circuit. The magnitudes of the observed effects on GME seem consistent with published dynamics of air microparticles in undersaturated aqueous solutions [12] . Of note, blood gas undersaturation is more important than denitrogenation alone. Our in vitro data demonstrate the difference between a denitrogenated normobaric oxygen control condition and a denitrogenated or undersaturated hypobaric oxygenation condition. An additional physical effect of subatmospheric pressures within the oxygenator's hollow fibers may contribute to oxygenator GME removal, but not to GME removal at more distal sites. Oxygenators under vacuum have been used previously to remove GME, but not to perform oxygenation, in vitro [11, 13] .
As the beneficial effect of hypobaric oxygenation on GME likely continues as blood flows into the patient, additional benefits may be realized on air entrained from the surgical field into the arterial circulation during openheart procedures. Hypobaric oxygenation should also ameliorate concerns about increased GME delivery due to pulsatile flow, centrifugal pump cavitation, and outgassing during vacuum-assisted venous drainage or with rapid temperature changes.
Tissue Effects
The reduction in brain microvascular injury in animals managed with hypobaric oxygenation suggests the possibility of improved end-organ function after CPB. While hypobaric oxygenation practically eliminated GME delivery, capillary dilations were only partially reduced. We suspect that the recycled mediastinal shed blood used to maintain the animals' hematocrit also increased lipid embolization and may account for residual microvascular damage seen in the hypobaric condition [14] . Also unknown is whether the small observed difference in PaCO 2 may have affected rates of cerebral embolization in our experiments.
Clinical Application
Hypobaric oxygenation does not change CPB circuit priming volumes, material composition, or ease of use. The perfusionist controls PaO 2 by adjusting the pressure of pure oxygen sweep gas rather than adjusting the sweep gas oxygen content, while PaCO 2 is still adjusted by varying the sweep gas flow rate. As partial pressures of anesthetic vapors are also reduced in proportion to the sweep gas pressure, an adjustment of anesthetic concentration will be necessary to ensure adequate anesthesia. As the oxygenator housing must be sealed in order to apply subatmospheric pressures, a suitable pressure relief system must exist to prevent gross air embolism in the event of occlusion of the sweep gas outlet or vacuum failure. Application of overly negative sweep gas pressures could result in hemoglobin desaturation, the solution for which would be to increase the sweep gas pressure or disconnect the vacuum source. Hypobaric oxygenation should be used along with, rather than instead of, arterial filtration in the CPB circuit. Among other benefits, arterial filtration reduces the size of GME, thereby increasing the surface-to-volume ratio and promoting rapid reabsorption under conditions of hypobaric oxygenation.
